Radiographic and magnetic resonances contrast agents: Essentials and tips for safe practices

doi:10.4329/wjr.v9.i9.339

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 9

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8211)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-8) series.

Item

Count

PDF

635

WORD

259

HTML

5444

Figures (1-1)

194

Tables (1-8)

190

Sum=6722

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

800

Download

689

Sum=1489

Sep 28, 2017 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Radiology

ISSN

1949-8470

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Radiol. Sep 28, 2017; 9(9): 339-349
Published online Sep 28, 2017. doi: 10.4329/wjr.v9.i9.339

Table 6 European medicines agency nephrogenic systemic fibrosis-risk stratification categorization of gadolinium-based contrast agent

GBCA NSF-risk class	Scientific (generic) name
Highest risk of NSF	Gadodiamide (Omniscan®)
	Gadopentetatedimeglumine (Magnevist®)
	Gadoversetamide (Optimark®)
Intermediate risk of NSF	Gadobenatedimeglumine (Multihance®)
	Gadofosvesettrisodium (Vasovist®, Ablavar®)
	Gadoxetate disodium (Primovist®, Eovist®)
Lowest risk of NSF	Gadobutrol (Gadovist®)
	Gadoteratemeglumine (Dotarem®)
	Gadoteridol (Prohance®)

NSF: Nephrogenic systemic fibrosis; GBCA: Gadolinium-based contrast agent.

Citation: Nouh MR, El-Shazly MA. Radiographic and magnetic resonances contrast agents: Essentials and tips for safe practices. World J Radiol 2017; 9(9): 339-349
URL: https://www.wjgnet.com/1949-8470/full/v9/i9/339.htm
DOI: https://dx.doi.org/10.4329/wjr.v9.i9.339